A cost comparison of radiotherapy and topical imiquimod for lentigo maligna treatment: considerations for clinical decision-making

Journal:

Journal of the American Academy of Dermatology

Published:

2025-12-20

DOI:

10.1016/j.jaad.2025.12.053

Affiliations:

23

Authors:

22

Go to article

Institutions	Authors	Share
The University of Sydney (USYD), Australia	4.900000	0.22
Melanoma Institute Australia, Australia	2.366667	0.11
Monash University, Australia	2.000000	0.09
University of Technology Sydney (UTS), Australia	2.000000	0.09
Royal Prince Alfred Hospital (RPAH), USYD, Australia	1.866667	0.08
Westmead Hospital (WSLHD), Australia	1.500000	0.07
Princess Alexandra Hospital, Australia	1.500000	0.07
Sydney Adventist Hospital, Australia	1.000000	0.05
Alfred Health, Australia	1.000000	0.05
Hospital das Clínicas da FMUSP, Brazil	1.000000	0.05
NSW Health Pathology, Australia	0.533333	0.02
The University of Queensland (UQ), Australia	0.500000	0.02
The University of Newcastle (UON), Australia	0.500000	0.02
Calvary Mater Newcastle, Australia	0.500000	0.02
Perth Dermatology Clinic, Australia	0.500000	0.02
The University of Auckland, New Zealand	0.333333	0.02

Interested in Applied Economics?